|1.||Edvinsson, Lars: 27 articles (01/2016 - 01/2002)|
|2.||Ohtori, Seiji: 26 articles (12/2015 - 09/2003)|
|3.||Takahashi, Kazuhisa: 25 articles (12/2015 - 04/2004)|
|4.||Goadsby, Peter J: 20 articles (10/2015 - 11/2002)|
|5.||Russo, Andrew F: 18 articles (06/2015 - 04/2002)|
|6.||Aoki, Yasuchika: 17 articles (10/2015 - 04/2004)|
|7.||Inoue, Gen: 17 articles (10/2015 - 10/2006)|
|8.||Li, Yuan-Jian: 17 articles (03/2013 - 05/2002)|
|9.||Orita, Sumihisa: 16 articles (10/2015 - 10/2009)|
|10.||Olesen, J: 16 articles (01/2012 - 05/2000)|
|1.||Migraine Disorders (Migraine)
09/01/2014 - "These results provide preliminary evidence that LY2951742 might be beneficial in migraine prevention and provide support for the role of calcitonin gene-related peptide in the pathogenesis of migraine. "
11/22/2002 - "It is proposed that clinically effective anti-migraine compounds, such as 5-HT(1B/1D) agonists, have actions that include inhibiting calcitonin gene-related peptide (CGRP) release from trigeminal nerves. "
11/01/2014 - "Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial."
09/01/2014 - "Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study."
09/01/2014 - "We assessed the safety and efficacy of LY2951742, a fully humanised monoclonal antibody to calcitonin gene-related peptide, for migraine prevention. "
01/01/2011 - "Clinical and experimental studies have revealed a central role of calcitonin gene-related peptide (CGRP) in primary headaches. "
07/01/2012 - "Calcitonin gene-related peptide (CGRP) is regarded as a key mediator in the generation of primary headaches. "
01/01/2011 - "The trigeminal ganglion and calcitonin gene-related peptide (CGRP) are crucial components in the pathophysiology of primary headaches. "
01/01/2011 - "Clinical and experimental results have revealed a fundamental role of calcitonin gene-related peptide (CGRP) in primary headaches. "
10/26/2010 - "Calcitonin gene-related peptide (CGRP) plays a fundamental role in the pathophysiology of neurovascular headaches. "
|3.||Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
10/27/2000 - "We sought to determine whether adenovirus-mediated gene transfer in vivo of calcitonin gene-related peptide (CGRP), a potent vasodilator, ameliorates cerebral vasoconstriction after experimental subarachnoid hemorrhage (SAH). "
11/01/1991 - "The authors propose that the marked decrease of calcitonin gene-related peptide immunoreactivity in the perivascular nerves, observed after experimental subarachnoid hemorrhage, is due to compensatory secretion of the peptide."
10/27/2000 - "Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage."
09/15/1995 - "The neuroprotective effect of calcitonin gene-related peptide following subarachnoid hemorrhage. "
09/01/1995 - "Effects of subarachnoid hemorrhage on vascular responses to calcitonin gene-related peptide and its related second messengers."
08/10/2013 - "Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure."
03/01/1990 - "Improved cardiac performance with human calcitonin gene related peptide in patients with congestive heart failure."
01/01/1994 - "Some studies have indicated that plasma calcitonin gene-related peptide (CGRP) increases in congestive heart failure (CHF). "
12/01/1992 - "Calcitonin gene-related peptide: a haemodynamic study of a novel vasodilator in patients with severe chronic heart failure."
11/01/1992 - "To investigate the role of calcitonin gene-related peptide (CGRP) in cardiac failure, a sensitive and specific radioimmunoassay was developed to study plasma levels of CGRP in 37 normal subjects and 41 patients with heart failure (HF). "
03/01/2011 - "The protective effects of calcitonin gene-related peptide on gastric mucosa injury of gastric ischemia reperfusion in rats."
08/01/1995 - "A study was undertaken to determine the effects of the topical vasodilator calcitonin gene-related peptide on the microcirculation of flaps after mechanically induced ischemia. "
01/01/1992 - "The effect of calcitonin-gene-related peptide on acute ischemia-reperfusion renal injury: ultrastructural and membrane lipid peroxidation studies."
02/01/2012 - "Intermedin (IMD)(1-53) is a novel member of the calcitonin gene-related peptide superfamily and has potent cardioprotective effects against myocardial injury induced by ischemia-reperfusion (I/R). "
02/01/2011 - "Calcitonin gene-related peptide facilitates revascularization during hindlimb ischemia in mice."
|1.||Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)
|3.||N- (6- (2,3- difluorophenyl)- 2- oxo- 1- (2,2,2- trifluoroethyl)azepan- 3- yl)- 4- (2- oxo- 2,3- dihydro- 1H- imidazo(4,5- b)pyridin- 1- yl)piperidine- 1- carboxamide
|5.||Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
|6.||calcitonin gene-related peptide (8-37)
|7.||Vasodilator Agents (Vasodilators)